Jung Cassie 4

What Happened
Cassie Jung, Chief Operating Officer of Aquestive Therapeutics (AQST), had 72,734 shares withheld by the company on May 5, 2026 to satisfy her tax withholding obligation related to vested Performance Stock Units (PSUs). The shares were valued at $4.18 each, totaling $304,028. This was a withholding to cover taxes, not an open-market sale.

Key Details

• Transaction date: 2026-05-05; Filing date: 2026-05-07 (filed within the normal Form 4 reporting window).
• Transaction type/code: F — shares withheld to satisfy tax liability.
• Shares withheld/disposed: 72,734 at $4.18 per share; total value $304,028.
• Footnote: Shares were withheld by the issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of previously granted PSUs.
• Shares owned after transaction: Not reported in the provided Form 4 excerpt.

Context
This is a routine tax-withholding transaction tied to PSU vesting (a common executive compensation event). Because the shares were surrendered to the company to cover taxes (not sold on the open market), it should not be interpreted as a directional buy/sell signal about executive sentiment. Purchases and open-market sales typically provide stronger signals for investor inference.